Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
580.43
14.46 (2.55%)
At close: Aug 15, 2025, 3:59 PM
579.00
-0.25%
After-hours: Aug 15, 2025, 07:57 PM EDT
Regeneron Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 4.46B | 4.5B | 4.41B | 4.65B | 4.32B | 3.86B | 3.95B | 3.99B | 4.3B | 4.18B | 4.34B | 5.37B | 5.69B | 7.93B | 8.08B | 7B | 6.21B | 4B |
Depreciation & Amortization | 510.1M | 495.7M | 482.9M | 469.5M | 453.2M | 435.6M | 421M | 408.1M | 395.3M | 366.6M | 341.4M | 315.8M | 296.4M | 293.1M | 286.2M | 273.4M | 259.5M | 247.2M |
Stock-Based Compensation | 1.04B | 1.01B | 982.8M | 918.8M | 897.6M | 876.4M | 885M | 876.6M | 839M | 796.8M | 725M | 681.4M | 652M | 637.7M | 601.7M | 534.8M | 499.1M | 457.1M |
Other Working Capital | 588.6M | 151.4M | 352.2M | 471.7M | -309.9M | 109.4M | 29M | -54.9M | 3.3M | -122.3M | -116.2M | -48.2M | -197.1M | -202.6M | -360.9M | -253.7M | -192.3M | -74.6M |
Other Non-Cash Items | -920.6M | 118.5M | 378.6M | 22.1M | 832.9M | 332.1M | 266.3M | 430.3M | 122.3M | 498.2M | 599.8M | 580.4M | 2.48B | -477.3M | -1.28B | -1.33B | -4.19B | -1.66B |
Deferred Income Tax | -723.1M | -706M | -757.3M | -763.4M | -720.5M | -811.7M | -837.8M | -831.2M | -791.2M | -737.9M | -746.4M | -672.6M | -579.9M | -382.2M | -147.1M | 16.5M | 9.4M | 75.8M |
Change in Working Capital | 511.2M | -397.3M | -86.4M | -61.4M | -721.7M | 105.5M | -94.1M | 349.3M | -125.6M | -825.6M | -243.3M | -980.7M | 1.15B | -553.9M | -1.92B | -1.6B | -4.38B | -1.86B |
Operating Cash Flow | 4.74B | 3.95B | 4.42B | 4.25B | 4.07B | 4.74B | 4.59B | 5.22B | 4.74B | 4.28B | 5.01B | 5.67B | 8.45B | 8.51B | 7.08B | 5.94B | 2.27B | 2.59B |
Capital Expenditures | -898.9M | -933M | -823.3M | -869.8M | -862.2M | -764.3M | -780.7M | -619.4M | -585.9M | -626.5M | -590.1M | -592.8M | -583.5M | -578.4M | -551.9M | -558.4M | -578.4M | -559.8M |
Cash Acquisitions | -11.5M | 3.6M | 3.6M | 11.3M | 211.2M | 330M | 430.9M | 2.05B | 590.1M | 225.9M | 1.69B | 623.5M | 1.89B | 2.12B | 551.9M | 614.6M | 614.6M | 614.6M |
Purchase of Investments | -11.94B | -13.5B | -16.62B | -16.8B | -15.45B | -15.55B | -11.65B | -12.66B | -9.98B | -6.93B | -7.49B | -6.52B | -8.94B | -8B | -7.05B | -5.47B | -3.59B | -3.89B |
Sales Maturities Of Investments | 12.47B | 14.35B | 15.03B | 14.83B | 13.57B | 11.78B | 9.44B | 8.6B | 7.43B | 6.6B | 5.55B | 4.33B | 3.18B | 2.55B | 2.22B | 2.35B | 2.16B | 3.76B |
Other Investing Acitivies | -288.3M | -472.2M | -1.98B | -1.79B | -2.01B | -1.79B | -442.5M | -2.35B | -1.74B | -1.61B | -2.98B | -3.12B | -5.76B | -5.45B | -4.83B | -3.12B | -1.44B | -126.6M |
Investing Cash Flow | -670.3M | -133.5M | -2.47B | -2.88B | -2.81B | -4.64B | -3.19B | -4.98B | -4.29B | -2.31B | -3.78B | -3.94B | -6.57B | -6.03B | -5.38B | -3.68B | -2.01B | -686.4M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 481.9M | 481.9M |
Common Stock Repurchased | -4.06B | -3.92B | -3.17B | -2.69B | -2.63B | -2.42B | -2.94B | -2.81B | -3.18B | -2.88B | -2.53B | -3.36B | -2.75B | -2.67B | -2.68B | -1.64B | -1.38B | -6.51B |
Dividend Paid | -186.4M | -93.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -680.8M | -680.8M | -680.8M |
Other Financial Acitivies | -1.16B | -1.15B | -497.3M | -955.4M | -931.2M | -947.3M | -700.6M | -431.6M | -411.1M | -443.9M | -445.7M | -839M | -999.7M | -977M | -1.03B | -450.3M | 122.4M | 1.65B |
Financial Cash Flow | -3.99B | -3.34B | -2.2B | -1.51B | -1.28B | -1.42B | -1.79B | -1.59B | -1.91B | -1.4B | -1.01B | -1.67B | -557.6M | -574.7M | -1.01B | -404.5M | -177.9M | -2.67B |
Net Cash Flow | 87.4M | 491M | -241M | -140.6M | -13.7M | -1.32B | -381.6M | -1.34B | -1.46B | 569.6M | 221.3M | 59.9M | 1.32B | 1.91B | 690.8M | 1.86B | 80M | -770.3M |
Free Cash Flow | 3.84B | 3.02B | 3.6B | 3.38B | 3.21B | 3.97B | 3.81B | 4.6B | 4.15B | 3.65B | 4.42B | 5.07B | 7.87B | 7.94B | 6.53B | 5.38B | 1.69B | 2.03B |